Raymond James Financial Services Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$444K	Sell
2024 Q2	$675K	Buy
2024 Q1	$647K	Buy